• UC San Diego breaks ground on 5-story vision center

    The University of California San Diego Shiley Eye Institute has broken ground on a five-story, 100,000-square-foot vision research center that will house labs, clinical trial operations and administrative and educational spaces. 
  • Ochsner Eye ASC founder dies at 83

    Ophthalmologist Bruce Ochsner, MD, founder of the Ochsner Eye Surgery Center in Wichita, Kan., died April 11 at 83, according to an obituary published in the Wichita Eagle.
  • Bausch + Lomb shakes up executive team

    Eye health company Bausch + Lomb has expanded its executive team, adding Bob Bailey as its executive vice president and chief legal officer and Andrew Stewart as its president of ophthalmic pharmaceuticals. 
  • Visus Therapeutics taps former Novartis leader

    Biopharmaceutical ophthalmologic company Visus Therapeutics has added former Novartis leader Jehan Tamboowalla as its senior vice president of business development and marketing. 
  • Unifeye Vision Partners gains 17th practice

    Unifeye Vision Partners has partnered with Kings Eye Center in Hanford, Calif.
  • 11 numbers ophthalmologists need to know

    Though one of the top 10 happiest physician specialties, ophthalmologists are still in short supply. 
  • FDA detects sterilization issues at recalled eye drop manufacturing facility

    A new report from the FDA alleges that Global Pharma Healthcare, manufacturer of the recalled EzriCare Artificial Tears Lubricant Eye Drops, did not follow the proper protocol to prevent product contamination at its production facilities, according to an April 3 report from CNN.
  • WVU opens satellite eye institute

    A satellite office of the West Virginia University Eye Institute in Morgantown has opened at WVU Medicine Wheeling (W.Va.) Hospital, according to an April 3 report from The Times Leader.
  • How many ophthalmologists are there in the US? 

    There are 18,948 total active ophthalmologists in the country, according to the Association of American Medical College's "2022 Physician Specialty Data Report."
  • Ascend Vision Partners adds 7th Florida practice

    Management services organization Ascend Vision Partners has partnered with Fort Lauderdale, Fla.-based Elgut Eye Care, its seventh partnership in the state. 
  • Dr. Francis Mah named chief medical adviser for Kala Pharmaceuticals

    Kala Pharmaceuticals, a biopharmaceutical eye disease company, has tapped Francis Mah, MD, as its new chief medical adviser, according to a March 29 news release published in Street Insider. 
  • Staar Surgical names new COO, chief clinical officer

    Staar Surgical Company, an implantable eye lens manufacturer, has selected Warren Foust as its new COO and Magda Michna, PhD, as its new chief clinical, regulatory and medical affairs officer. 
  • 4 changes the American Academy of Ophthalmology seeks in prior authorization rule

    The American Academy of Ophthalmology has commented on CMS' proposed prior authorization rule.
  • Maine hospital cuts eye surgeries: What ASCs should know

    Brewer, Maine-based Northern Light Health has cut several eye surgeries from Eastern Maine Medical Center in Bangor, Maine, Bangor Daily News reported March 26.
  • False claim allegations and recalled eye drops: 10 ophthalmology updates in 3 weeks

    From a $2.9 million false claim allegation to three deaths linked to bacterial infections caused by artificial tears, here are 10 ophthalmology updates since March 6. 
  • 2 more eye drops recalled in response to contamination risks

    Pharmedica and Apotex voluntarily recalled several lots of their products due to contamination risks, according to the FDA.
  • Texas ophthalmology practice pays $2.9M to settle false claim allegations

    Arlington, Texas-based ophthalmology provider Kleiman Evangelista Eye Centers will pay $2.9 million to resolve false claim allegations that it paid kickbacks to optometrists to induce referrals of cataract surgery patients. 
  • 3 deaths now linked to recalled eye drops

    Global Pharma Healthcare recalled its Artificial Tears Lubricant Eye Drops, distributed by EzriCare and Delsam Pharma, last month after they were linked to a rare strain of bacteria, according to a March 22 report from NBC affiliate KSL TV.
  • Winter Park Ophthalmology joins Ascend Vision Partners

    Winter Park (Fla.) Ophthalmology has joined management services company Ascend Vision Partners. 
  • FTC proposes changes to ophthalmology prescription laws

    The Federal Trade Commission is holding a public workshop on May 18 to allow comments on its proposed update to the Ophthalmic Practice Rules, commonly known as the Eyeglass Rule, which would require ophthalmologists and optometrists to get a signed statement from patients confirming the receipt of a prescription copy. 

Featured Webinars

Featured Whitepapers

Featured Podcast